These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 8215293

  • 1. In vitro postantibiotic effect following repeated exposure to imipenem, temafloxacin, and tobramycin.
    McGrath BJ, Marchbanks CR, Gilbert D, Dudley MN.
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1723-5. PubMed ID: 8215293
    [Abstract] [Full Text] [Related]

  • 2. Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy.
    Aubert G, Pozzetto B, Dorche G.
    J Antimicrob Chemother; 1992 Mar; 29(3):307-12. PubMed ID: 1317371
    [Abstract] [Full Text] [Related]

  • 3. The influence of postantibiotic effects and postantibiotic effects of sub-inhibitory concentrations of quinolones and aminoglycosides on phospholipase C of Pseudomonas aeruginosa.
    Hybenová D, Majtán V.
    Pharmazie; 1997 Feb; 52(2):157-9. PubMed ID: 9122276
    [Abstract] [Full Text] [Related]

  • 4. Different patterns of bacterial DNA synthesis during postantibiotic effect.
    Gottfredsson M, Erlendsdóttir H, Gudmundsson A, Gudmundsson S.
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1314-9. PubMed ID: 7574522
    [Abstract] [Full Text] [Related]

  • 5. Development of quinolone-imipenem cross resistance in Pseudomonas aeruginosa during exposure to ciprofloxacin.
    Rådberg G, Nilsson LE, Svensson S.
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2142-7. PubMed ID: 2127345
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of the bactericidal activity of temafloxacin.
    Jacobs MR.
    Am J Med; 1991 Dec 30; 91(6A):31S-34S. PubMed ID: 1662893
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impact of pharmacokinetics on the postantibiotic effect exhibited by Pseudomonas aeruginosa following tobramycin exposure: application of an in-vitro model.
    Zhu ZY, Li RC.
    J Antimicrob Chemother; 1998 Jul 30; 42(1):61-5. PubMed ID: 9700529
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In-vitro postantibiotic effect of sparfloxacin and ciprofloxacin against Pseudomonas aeruginosa and Enterococcus faecalis.
    Pastor A, Pemán J, Cantón E.
    J Antimicrob Chemother; 1994 Nov 30; 34(5):679-85. PubMed ID: 7706163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.